Status:
RECRUITING
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Lead Sponsor:
Aura Biosciences
Conditions:
Choroidal Melanoma
Indeterminate Lesions of Eye
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care therapy, etc.) while partic...
Detailed Description
This is a multi-center long-term observational Registry of subjects with Primary Indeterminate Lesions or Choroidal Melanoma. The Registry will initially be open to subjects who have previously parti...
Eligibility Criteria
Inclusion Criteria:
- Have been clinically diagnosed with primary IL or CM at the time of entry to a previous Aura Biosciences sponsored clinical trial.
- Have received AU-011 bel-sar or assigned to a different cohort or treatment arm (sham, SoC, etc.) an observation cohort in a previous Aura sponsored clinical trial.
Exclusion Criteria:
- None
Key Trial Info
Start Date :
March 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03941379
Start Date
March 27 2019
End Date
December 1 2029
Last Update
December 21 2023
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Retina Associates SW, P.C.
Tucson, Arizona, United States, 85710
2
UCLA Jules Stein Eye Institute
Los Angeles, California, United States, 90095
3
Byers Eye Institute at Stanford University
Palo Alto, California, United States, 94303
4
Retina Consultants of Sacramento
Sacramento, California, United States, 95825